The effect of Montelukast on bladder hyperactivity

Phase 3

• Conditions: Overactive bladder.; Other specified urinary incontinence; N39.4

• Registration Number: IRCT20210212050333N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Children with bladder hyperactivity 3-17 years old

Exclusion Criteria

History of allergy to Monteluca

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequent urination. Timepoint: Frequent urination was measured at the beginning of the study and 10 days after starting Montelukast. Method of measurement: questionnaire.;Frequent urgency incontinence. Timepoint: Measuring the incidence of urgent incontinence at the beginning of the study and 10 days after starting Montelukast. Method of measurement: questionnaire.;Frequent urinary urgency. Timepoint: Measure the frequency of urinary urgency at the beginning of the study and 10 days after starting Montelukata. Method of measurement: questionnaire.